CDC HAN on Chloroquine as Seen on TV

CDC has released a new HAN Health Alert Advisory on Severe Illness Associated with Using Non-Pharmaceutical Chloroquine Phosphate to Prevent and Treat COVID-19.  The Summary includes “Chloroquine phosphate, when used without a prescription and supervision of a healthcare provider, can cause serious health consequences, including death.  Clinicians and public health officials should discourage the public from misusing non-pharmaceutical chloroquine phosphate (a chemical used in home aquariums).  Clinicians should advise patients and the public that chloroquine, and the related compound hydroxychloroquine, should be used only under the supervision of a healthcare provider as prescribed medications.”  Find the CDC HAN at

CW January New User Training, Newsletter

CROWNWeb has published their January Newsletter, at  It includes articles on

  • Medication Reconciliation and its January 9 and 23, 2020 training sessions
  • PY2020 PSRs and PSCs (see also
  • ICH CAHPS CY2019 exemption attestation (deadline March 2, 2020)
  • CY2020 Clinical Depression Screening requirements
  • January 16, 2020 training for ICH CAHPS and Depression Screening reporting requirements
  • Clinical data submission deadlines (if your Network doesn’t require earlier submission)

Plus announcement of the January 21, 2020 New User Training, and the usual lists of always-useful resources and links.

Find information and register for the January 30, 2020 CROWNWeb Town Hall on signing up for HCQIS HARP at

1/1 MedRec QIP Measure in EQRS/CW

CMS has released an updated version of EQRS/CROWNWeb that supports QIP CY2020 data reporting requirements.  It includes Medication Reconciliation (“MedRec”) fields on the CROWNWeb Manage Clinical screens.  The QIP MedRec Reporting Measure requirement, which assesses evaluation of patients’ medication, begins with PY2022, and data reporting for it begins January 2020 for all HD and PD patients.  Facilities don’t need to enter MedRec data into EQRS/CROWNWeb during 2019; however, the new release allows review of the MedRec fields in preparation for use in 2020.  A draft of Version 5.0 of the CMS ESRD Measures Manual for the 2020 Performance Period includes a chapter on the MedRec Measure (pp. 147-151); find it at

For assistance with EQRS/CROWNWeb or the ESRD QIP, contact the ESRD QIP Support Team using the ESRD QIP Q&A Tool at  If you have questions or concerns on use of the ESRD QIP application, contact the QualityNet Help Desk at or 866-288-8912, 5am-5pm PT, Monday-Friday.

12/19 CROWNWeb Town Hall, Newsletter

CROWNWeb will hold their next Town Hall on December 19, 3019 on Understanding the Payment Year 2020 ESRD QIP Final Performance Score ReportRegister at

The December CROWNWeb Newsletter is also now available, at  The lead article reviews 2019 and previews 2020, and announces upcoming CROWNWeb modifications on medication reconciliation, ICH CAHPS, and Depression Screening/Followup.  The Newsletter also includes its usual tables of Clinical Closing dates and extensive links to Resources, and a preview of CROWNWeb events in 2020, including (updated 12/31/19):

  • New User Trainings will move to the third Tuesday of each month (January 21, 2020).
  • CROWNWeb Town Halls will be held on the third Thursday of each month (except in January it will be the fourth Thursday, January 30, 2020).
  • Training for Medication Reconciliation (January 9 and 23), ICH CAHPS and Depression Screening (January 16), and the new HARP (HCPIS Access Roles and Profile) account management application (at the January 30 Town Hall) will also be held in January.
  • Training for 2744 will be held in Spring 2020, date tba.

CDC Opioids Online Training

CDC has added a twelfth module to its free-CE series of online on-demand opioid training modules, Applying CDC’s Guideline for Prescribing Opioids: An Online Training Series for Healthcare Providers.  The new module is called A Nurse’s Call to Action for Safer Opioid Prescribing.  Fine the new module at, and the other eleven modules at

8/21 CDC and OHA on Infection Prevention

CDC’s webpage on the Making Dialysis Safer for Patients Coalition includes links to many posters, audit tools, checklists and fact sheets for use in providers’ offices, dialysis clinics, training sessions, work areas, and similar resources for patients.  It also includes recordings of free continuing-education webinars on infection prevention in dialysis clinics, plus past and current coalitionNEWSLETTERs.  Find this CDC web page at  CDC also publishes a Safe Healthcare Blog, at

Making Dialysis Safer Coalition

The latest Oregon One and Only Campaign Newsletter contains articles on:

  • Single-dose and multiple-dose vials, including a link to a CDC infographic on it
  • An August 21, 2019 webinar on drug diversion and a link to the Council of State and Territorial Epidemiologists’s HAI Drug Diversion Planning and Response Toolkit for State and Local Health Departments
  • An example of multiple acute HCV infections caused by using a single-dose vial for multiple patients

Find the newsletter at and the Oregon Health Authority’s HAI Prevention webpage at

8/7 CCCC Webinar on Medical Cannabis

The Coalition for Compassionate Care of California will present an August 8, 2019 webinar on Medical Cannabis: Patient Education for Safe and Effective Use.  Continuing Education credits are available for nurses and social workers.  For details and registration see

NW16 6/28 WA DOH Webinar re Drugs

The Washington State Department of Health will hold a 1pm PDT June 28, 2019 meeting and webinar on the legality of the sale, delivery, and possession of specific preparations of heparin, dialysate, and KCL or NaCl for injection (“legend drugs”: see, and other drugs, by dialysis clinics.  The purpose of the meeting is to discuss and clarify the kinds of licensing required by Washington State law.  For details see

From a meeting announcement memo: “The [Washington State] Pharmacy Commission has been asked by the [Washington] DOH Office of Health System Oversight (OHSO) for guidance on the statutory authority of ESRD or Kidney Dialysis Centers to sell, deliver, or possess legend drugs.  The Pharmacy Commission and OHSO staff would like to hold a stakeholder meeting to present initial findings from the staff research and obtain input from stakeholders.  Following the stakeholder meeting the Pharmacy Commission and OHSO staff will prepare an Interpretive Statement to provide guidance to the provider community and [DOH].”

To attend the meeting in person: Room 158, Town Center 2, Tumwater campus, 111 Israel Rd SE, Tumwater WA 98501.  To attend the meeting by webinar, register at; further instructions will be sent to you by email.  For questions or comments contact